参天製薬株式会社 group: subsidiaries and structure
株式会社 (株) · 大阪府 大阪市北区, Japan · LEI 529900TPT3I7C17MIM03
2subsidiaries
2countries
1held directly
1lapsed LEIs
2links on accounts older than 24 months
0ISINs of subsidiaries
Summary
参天製薬株式会社 is the ultimate parent of 2 subsidiaries with LEIs in 2 countries, as reported to GLEIF. 1 is held directly; the others sit below intermediate companies. The largest numbers are in Spain (1) and in Finland (1). 1 of the subsidiaries has a lapsed LEI, and 2 links rest on accounts older than 24 months. GLEIF's ISIN mapping lists 2 ISINs for the parent and 0 ISINs for its subsidiaries.
Written from GLEIF data using fixed, reviewed sentence templates.
Subsidiaries by country
Data-quality notes (AssetCensus analysis)
No group-level data-quality notes in this data release.
2 subsidiaries have data-quality notes; they are listed on each company page.
Group structure
Indentation shows the direct parent reported to GLEIF.
Santen Oy Finland
Subsidiaries
| Company | Country | City | LEI | Accounts year | Notes |
|---|---|---|---|---|---|
| SANTEN PHARMACEUTICAL SPAIN SL | Spain | Madrid | 959800KWNTB2NDZCUC86 | 2021 | lapsed > 24 months |
| Santen Oy | Finland | TAMPERE | 7437004Z9N9458119O18 | 2018 | > 24 months |